NR

Nageswara Rao Madamanchi

Active Director Director DIN 07373421
DIN 07373421 First appointment Jun 2016 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Nageswara Rao Madamanchi

Data last updated:

Nageswara Rao Madamanchi is a Director at Maheswari Biotech Private Limited (since 2016). The company operates in Chemicals.

DIN 07373421
Primary Designation Director
Industry Chemicals
First Appointment 22 Jun 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maheswari Biotech Private Limited U24290TG2016PTC110438
Director22 Jun 20162016Active

Board colleagues of Nageswara Rao Madamanchi

NameDINCompanyDesignation
Sreedhar Madamanchi07371022Maheswari Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Maheswari Biotech Private Limited
Premium access

Shareholding and investment profile for Nageswara Rao Madamanchi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nageswara Rao Madamanchi

Nageswara Rao Madamanchi currently holds 1 directorship: Maheswari Biotech Private Limited (Director, since 22 Jun 2016).

Nageswara Rao Madamanchi was first appointed on 22 Jun 2016 as Director at Maheswari Biotech Private Limited.

The current boards of Nageswara Rao Madamanchi's companies include Sreedhar Madamanchi (Maheswari Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available